Expression of CD70 and the TH17 transcription factor RORγT in human contact dermatitis

Journal of Drugs in Dermatology

Volumn 7, Issue 10, 2008, Pages 956-960

  Martiniuk, Frank ^a   Lee, David S ^b   Gaspari, Anthony ^c   Yee, Herman ^a   Chiriboga, Luis ^a   Huie, Maryann ^a   Tchou Wong, Kam Meng ^a   Levis, William R ^d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD70 ANTIGEN; IMMUNOLOGIC FACTOR; ORPHAN NUCLEAR RECEPTOR ROR GAMMA; ORPHAN NUCLEAR RECEPTOR ROR-GAMMA; RETINOIC ACID RECEPTOR; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ARTICLE; BIOSYNTHESIS; CONTACT DERMATITIS; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; TISSUE FIXATION;

ANTIGENS, CD70; DERMATITIS, CONTACT; ELECTROPHORESIS, AGAR GEL; HUMANS; IMMUNOLOGIC FACTORS; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; TISSUE FIXATION;

EID: 59049090264     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Holzer AM, Kaplan LL, Levis WR. Haptens as drugs: contact allergens are powerful topical immunomodulators. J Drugs Dermatol. 2006;5:410-416.
2. Holzer AM, Levis WR. Antiviral immunotherapy: emerging approaches with relevance to cutaneous disease. Expert Reviews Dermatology. 2007;2:619-627. (Pubitemid 350065063)
3. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol. 2004;22:817-890. (Pubitemid 38680443)
4. Gober MD, Fishelevich R, Zhao Y, Unutmaz D, Gaspari AA. Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis. J Invest Dermatol. 2008;128:1460-1469. (Pubitemid 351693190)
5. Gober MD, Gaspari AA. Allergic contact dermatitis. Curr Dir Autoimmun. 2008;10:1-26.
6. Brownell I. Sexy and 17: TH17 effector T cells and psoriasis. J Drugs Dermatol. 2007;6:853-856.
7. Watanabe H, Gehrke S, Contassot E, Roques S, Tschopp J, Friedmann PS, French LE, Gaide O. Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J Immunol. 2008;180:5826-5832.
8. Taraban VY, Martin S, Attfield KE, et al. Invariant NKT cells promote CD8+ cytotoxic T cell responses by inducing CD70 expression on dendritic cells. J Immunol. 2008;180:4615-4620.
9. Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol. 2007;19:409-417. (Pubitemid 351274050)
10. Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammaT directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121-1133. (Pubitemid 44380299)
11. Belsito DV. Patch testing with a standard allergen ("screening" ) tray: rewards and risks. Dermatol Ther. 2004;17:231-239. (Pubitemid 38823471)
12. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 1974;248:701-702.
13. Shearer GM. Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes. Eur J Immunol. 1974;4:527-533.
14. Shaw S, Levis WR, Dattner AM, Shearer GM. Specificity of human cytotoxic responses to chemically modified autologous cells. Transplant Proc. 1978;10:937-941. (Pubitemid 9113867)
15. Levis WR, Dattner AM. Clonal priming of lymphocytes can measure human immune-response gene function. N Engl J Med. 1977;297:842-843.
16. Seldin MF, Rich RR. Human immune responses to hapten-conjugated cells. I. Primary and secondary proliferative responses in vitro. J Exp Med. 1978;147:1671-1683. (Pubitemid 8372960)
17. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348-2357. (Pubitemid 16136806)
18. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 1989;54:1-13.
19. Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol. 1997;9:4-9. (Pubitemid 27095892)
20. Shevach EM. Special regulatory T cell review: How I became a T suppressor/regulatory cell maven. Immunology. 2008;123:3-5. (Pubitemid 350256013)
21. Muranski P, Boni A, Antony PA, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 2008;112:362-373.
22. Radhakrishnan S, Cabrera R, Schenk EL, et al. Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo. J Immunol. 2008;181:3137-3147.
23. Agarwal A, Newell KA. The role of positive costimulatory molecules in transplantation and tolerance. Curr Opin Organ Transplant. 2008;13:366-732.
24. Mars LT, Gautron AS, Novak J, et al. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. Immunol. 2008;181:2321-2329.
25. Huang J, Kerstann KW, Ahmadzadeh M, et al. Modulation by IL-2 of CD70 and CD27 Expression on CD8+ T Cells: Importance for the therapeutic effectiveness of cell transfer immunotherapy. J. Immunol., 2006;176:7726-7735. (Pubitemid 43849073)
26. Damian DL, Thompson JF. Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone. J Am Acad Dermatol. 2007;56:869-871. (Pubitemid 46578262)
27. Keller AM, Groothuis TA, Veraar EA, et al. Costimulatory ligand CD70 is delivered to the immunological synapse by shared intracellular trafficking with MHC class II molecules. Proc Natl Acad Sci. 2007;104:5989-5994. (Pubitemid 47175646)
28. Vossen MT, Matmati M, Hertoghs KM, et al. CD27 defines phenotypically and functionally different human NK cell subsets. Immunol. 2008;180:3739-3745.
29. Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-17-depen-dent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest. 2007;117:3498-3506. (Pubitemid 350097005)
30. O'Leary JG, Goodarzi M, Drayton DL, Von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol. 2006;7:507-516.
31. Ambrosino E, Berzofsky JA, Terabe M. Regulation of tumor immunity: the role of NKT cells. Expert Opin Biol Ther. 2008;8:725-734. (Pubitemid 351860202)
32. Watanabe H, Gaide O, Pétrilli V, et al, French LE. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol. 2007;127:1956-1963. (Pubitemid 47075373)
33. Yazdi AS, Ghoreschi K, Röcken M. Inflammasome activation in delayed-type hypersensitivity reactions. J Invest Dermatol. 2007;127:1853-1855. (Pubitemid 47075370)
34. Watanabe H, Gehrke S, Contassot E, et al. Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J. Immunol., 2008;180:5826-5832.